Global Diagnostic Radiopharmaceuticals & Contrast Media Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

1.1 Research Scope

1.2 Top Diagnostic Radiopharmaceuticals & Contrast Media Manufacturers Covered: Ranking by Revenue

1.3 Market Segment by Type

1.3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)

1.3.2 Radiopharmaceuticals

1.3.3 Contrast Media

1.4 Market Segment by Application

1.4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Application: 2015 VS 2020 VS 2026

1.4.2 Hospital

1.4.3 Clinic

1.4.4 Other

1.5 Study Objectives

1.6 Years Considered

2 Global Market Perspective

2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity Analysis

2.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value (2015-2026)

2.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Production (2015-2026)

2.1.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Capacity (2015-2026)

2.1.4 Global Diagnostic Radiopharmaceuticals & Contrast Media Marketing Pricing and Trends

2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Growth Potential by Key Producing Regions

2.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Key Producing Regions: 2015 VS 2021 VS 2026

2.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Key Producing Regions: 2021 VS 2026

2.3 Industry Trends

2.3.1 Diagnostic Radiopharmaceuticals & Contrast Media Market Trends

2.3.2 Diagnostic Radiopharmaceuticals & Contrast Media Market Drivers

2.3.3 Diagnostic Radiopharmaceuticals & Contrast Media Market Challenges

2.3.4 Diagnostic Radiopharmaceuticals & Contrast Media Market Restraints

2.3.5 Primary Interviews with Key Diagnostic Radiopharmaceuticals & Contrast Media Players: Views for Future

3 Market Share by Manufacturers

3.1 Global Top Manufacturers by Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity

3.1.1 Global Top Manufacturers by Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity (2015-2020)

3.1.2 Global Top Manufacturers by Diagnostic Radiopharmaceuticals & Contrast Media Production (2015-2020)

3.1.3 Global 5 and 10 Largest Manufacturers by Diagnostic Radiopharmaceuticals & Contrast Media Production in 2019

3.2 Global Top Manufacturers by Diagnostic Radiopharmaceuticals & Contrast Media Revenue

3.2.1 Global Top Manufacturers by Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2015-2020)

3.2.2 Global Top Manufacturers Market Share by Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2015-2020)

3.2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Concentration Ratio (CR5 and HHI)

3.3 Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Radiopharmaceuticals & Contrast Media as of 2019)

3.4 Global Diagnostic Radiopharmaceuticals & Contrast Media Average Selling Price (ASP) by Manufacturers

3.5 Key Manufacturers Diagnostic Radiopharmaceuticals & Contrast Media Plants/Factories Distribution and Area Served

3.6 Date of Key Manufacturers Enter into Diagnostic Radiopharmaceuticals & Contrast Media Market

3.7 Key Manufacturers Diagnostic Radiopharmaceuticals & Contrast Media Product Offered

3.8 Mergers & Acquisitions, Expansion Plans

4 Estimate and Forecast by Type (2015-2026)

4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Historic Market Size by Type (2015-2020)

4.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Production Market Share by Type (2015-2020)

4.1.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value Market Share by Type

4.1.4 Diagnostic Radiopharmaceuticals & Contrast Media Average Selling Price (ASP) by Type (2015-2020)

4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Forecast by Type (2021-2026)

4.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Production Market Share Forecast by Type (2021-2026)

4.2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value Market Share Forecast by Type

4.2.4 Diagnostic Radiopharmaceuticals & Contrast Media Average Selling Price (ASP) Forecast by Type (2021-2026)

4.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

5.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Application (2015-2020)

5.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Application (2021-2026)

6 Production by Regions: Market Fact & Figures

6.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Production (History Data) by Regions (2015-2020)

6.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value (History Data) by Regions

6.3 North America

6.3.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Production Growth Rate (2015-2020)

6.3.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Production Value Growth Rate (2015-2020)

6.3.3 Key Players Market Share in North America

6.3.4 North America Diagnostic Radiopharmaceuticals & Contrast Media Import & Export (2015-2020)

6.4 Europe

6.4.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Production Growth Rate (2015-2020)

6.4.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Production Value Growth Rate (2015-2020)

6.4.3 Key Players Market Share in Europe

6.4.4 Europe Diagnostic Radiopharmaceuticals & Contrast Media Import & Export (2015-2020)

6.5 China

6.5.1 China Diagnostic Radiopharmaceuticals & Contrast Media Production Growth Rate (2015-2020)

6.5.2 China Diagnostic Radiopharmaceuticals & Contrast Media Production Value Growth Rate (2015-2020)

6.5.3 Key Players Market Share in China

6.5.4 China Diagnostic Radiopharmaceuticals & Contrast Media Import & Export (2015-2020)

6.6 Japan

6.6.1 Japan Diagnostic Radiopharmaceuticals & Contrast Media Production Growth Rate (2015-2020)

6.6.2 Japan Diagnostic Radiopharmaceuticals & Contrast Media Production Value Growth Rate (2015-2020)

6.6.3 Key Players Market Share in Japan

6.6.4 Japan Diagnostic Radiopharmaceuticals & Contrast Media Import & Export (2015-2020)

7 Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Regions: Market Fact & Figures

7.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption (History Data) by Regions (2015-2020)

7.2 Global Top Diagnostic Radiopharmaceuticals & Contrast Media Consumers (regions/countries) Ranking and Share of Total Diagnostic Radiopharmaceuticals & Contrast Media Consumption in 2015 VS 2019

7.3 North America

7.3.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Type

7.3.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Application

7.3.3 North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Countries

7.3.4 U.S.

7.3.5 Canada

7.4 Europe

7.4.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Type

7.4.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Application

7.4.3 Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Countries

7.4.4 Germany

7.4.5 France

7.4.6 U.K.

7.4.7 Italy

7.4.8 Russia

7.5 Asia Pacific

7.5.1 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Type

7.5.2 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Application

7.5.3 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Regions

7.5.4 China

7.5.5 Japan

7.5.6 South Korea

7.5.7 India

7.5.8 Australia

7.5.9 Taiwan

7.5.10 Indonesia

7.5.11 Thailand

7.5.12 Malaysia

7.5.13 Philippines

7.5.14 Vietnam

7.6 Central & South America

7.6.1 Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Type

7.6.2 Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Application

7.6.3 Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Countries

7.6.4 Mexico

7.6.5 Brazil

7.6.6 Argentina

7.7 Middle East and Africa

7.7.1 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Type

7.7.2 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Application

7.7.3 Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Countries

7.7.4 Turkey

7.7.5 Saudi Arabia

7.7.6 UAE

8 Company Profiles

8.1 Amag Pharmaceuticals

8.1.1 Amag Pharmaceuticals Corporation Information

8.1.2 Amag Pharmaceuticals Business Overview

8.1.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)

8.1.4 Diagnostic Radiopharmaceuticals & Contrast Media Products and Services

8.1.5 Amag Pharmaceuticals SWOT Analysis

8.1.6 Amag Pharmaceuticals Recent Developments

8.2 Bayer Healthcare

8.2.1 Bayer Healthcare Corporation Information

8.2.2 Bayer Healthcare Business Overview

8.2.3 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)

8.2.4 Diagnostic Radiopharmaceuticals & Contrast Media Products and Services

8.2.5 Bayer Healthcare SWOT Analysis

8.2.6 Bayer Healthcare Recent Developments

8.3 Bracco Imaging

8.3.1 Bracco Imaging Corporation Information

8.3.2 Bracco Imaging Business Overview

8.3.3 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)

8.3.4 Diagnostic Radiopharmaceuticals & Contrast Media Products and Services

8.3.5 Bracco Imaging SWOT Analysis

8.3.6 Bracco Imaging Recent Developments

8.4 Daiichi Sankyo

8.4.1 Daiichi Sankyo Corporation Information

8.4.2 Daiichi Sankyo Business Overview

8.4.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)

8.4.4 Diagnostic Radiopharmaceuticals & Contrast Media Products and Services

8.4.5 Daiichi Sankyo SWOT Analysis

8.4.6 Daiichi Sankyo Recent Developments

8.5 GE Healthcare

8.5.1 GE Healthcare Corporation Information

8.5.2 GE Healthcare Business Overview

8.5.3 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)

8.5.4 Diagnostic Radiopharmaceuticals & Contrast Media Products and Services

8.5.5 GE Healthcare SWOT Analysis

8.5.6 GE Healthcare Recent Developments

8.6 Guerbet

8.6.1 Guerbet Corporation Information

8.6.2 Guerbet Business Overview

8.6.3 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)

8.6.4 Diagnostic Radiopharmaceuticals & Contrast Media Products and Services

8.6.5 Guerbet SWOT Analysis

8.6.6 Guerbet Recent Developments

8.7 Lantheus

8.7.1 Lantheus Corporation Information

8.7.2 Lantheus Business Overview

8.7.3 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)

8.7.4 Diagnostic Radiopharmaceuticals & Contrast Media Products and Services

8.7.5 Lantheus SWOT Analysis

8.7.6 Lantheus Recent Developments

8.8 Mallinckrodt

8.8.1 Mallinckrodt Corporation Information

8.8.2 Mallinckrodt Business Overview

8.8.3 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)

8.8.4 Diagnostic Radiopharmaceuticals & Contrast Media Products and Services

8.8.5 Mallinckrodt SWOT Analysis

8.8.6 Mallinckrodt Recent Developments

8.9 Medtronic

8.9.1 Medtronic Corporation Information

8.9.2 Medtronic Business Overview

8.9.3 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)

8.9.4 Diagnostic Radiopharmaceuticals & Contrast Media Products and Services

8.9.5 Medtronic SWOT Analysis

8.9.6 Medtronic Recent Developments

8.10 Nordion

8.10.1 Nordion Corporation Information

8.10.2 Nordion Business Overview

8.10.3 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)

8.10.4 Diagnostic Radiopharmaceuticals & Contrast Media Products and Services

8.10.5 Nordion SWOT Analysis

8.10.6 Nordion Recent Developments

9 Diagnostic Radiopharmaceuticals & Contrast Media Production Side by Producing Regions (Countries)

9.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value Forecast by Region (2021-2026)

9.2 Diagnostic Radiopharmaceuticals & Contrast Media Production Forecast by Regions

9.3 Key Diagnostic Radiopharmaceuticals & Contrast Media Producing Regions Forecast

9.3.1 North America

9.3.2 Europe

9.3.3 China

9.3.4 Japan

10 Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Top Consumers (Regions/Countries)

10.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Region (2021-2026)

10.2 North America Market Consumption YoY Growth Forecast

10.2.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption YoY Growth (2021-2026)

10.2.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Country (2021-2026)

10.3 Europe Market Consumption YoY Growth Forecast

10.3.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption YoY Growth (2021-2026)

10.3.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Country (2021-2026)

10.4 Asia Pacific Market Consumption YoY Growth Forecast

10.4.1 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Consumption YoY Growth (2021-2026)

10.4.1 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Regions (2021-2026)

10.5 Latin America Market Consumption YoY Growth Forecast

10.5.1 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Consumption YoY Growth (2021-2026)

10.5.2 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Country (2021-2026)

10.6 Middle East and Africa Market Consumption YoY Growth Forecast

10.6.1 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption YoY Growth (2021-2026)

10.6.2 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Country (2021-2026)

11 Value Chain and Sales Channels Analysis

11.1 Diagnostic Radiopharmaceuticals & Contrast Media Value Chain Analysis

11.2 Sales Channels Analysis

11.2.1 Diagnostic Radiopharmaceuticals & Contrast Media Sales Channels

11.2.2 Diagnostic Radiopharmaceuticals & Contrast Media Distributors

11.3 Diagnostic Radiopharmaceuticals & Contrast Media Customers

12 Key Findings

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

Table 1. Diagnostic Radiopharmaceuticals & Contrast Media Key Market Segments

Table 2. Ranking of Global Top Diagnostic Radiopharmaceuticals & Contrast Media Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)

Table 4. Major Manufacturers of Radiopharmaceuticals

Table 5. Major Manufacturers of Contrast Media

Table 6. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application 2021-2026 (K Units)

Table 7. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity of Key Manufacturers (K Units)

Table 8. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Growth Rate by Region: 2015 VS 2021 VS 2026 (US$ Million)

Table 9. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size of Key Regions (US$ Million) & (K Units)

Table 10. Market Top Trends

Table 11. Key Drivers: Impact Analysis (2021-2026)

Table 12. Main Points Interviewed from Key Diagnostic Radiopharmaceuticals & Contrast Media Players: Views for Future

Table 13. Global Diagnostic Radiopharmaceuticals & Contrast Media Capacity by Manufacturers (2015-2020) (K Units)

Table 14. Global Diagnostic Radiopharmaceuticals & Contrast Media Capacity Market Share by Manufacturers (2015-2020)

Table 15. Global Diagnostic Radiopharmaceuticals & Contrast Media Production by Manufacturers (2015-2020) (K Units)

Table 16. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Share by Manufacturers (2015-2020)

Table 17. Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Manufacturers (2015-2020) (US$ Million)

Table 18. Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Manufacturers (2015-2020)

Table 19. Global Diagnostic Radiopharmaceuticals & Contrast Media Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 20. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Radiopharmaceuticals & Contrast Media as of 2019)

Table 21. Global Diagnostic Radiopharmaceuticals & Contrast Media Average Selling Price (ASP) by Manufacturers (2015-2020) (US$/Unit)

Table 22. Key Manufacturers Diagnostic Radiopharmaceuticals & Contrast Media Plants/Factories Distribution

Table 23. Key Manufacturers Diagnostic Radiopharmaceuticals & Contrast Media Area Served

Table 24. Date of Key Manufacturers Enter into Diagnostic Radiopharmaceuticals & Contrast Media Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Key Manufacturers Diagnostic Radiopharmaceuticals & Contrast Media Product Type

Table 27. Global Radiopharmaceuticals Production and Production Value (2015-2020) (K Units) & (US$ Million)

Table 28. Global Contrast Media Production and Production Value (2015-2020) (K Units) & (US$ Million)

Table 29. Global Diagnostic Radiopharmaceuticals & Contrast Media Production by Type (2015-2020) (K Units)

Table 30. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Share by Type (2015-2020)

Table 31. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value by Type (2015-2020) (US$ Million)

Table 32. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value Share by Type (2015-2020)

Table 33. Diagnostic Radiopharmaceuticals & Contrast Media Average Selling Price (ASP) by Type 2015-2020 (US$/Unit)

Table 34. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Forecast by Type (2021-2026) (K Units)

Table 35. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Share Forecast by Type (2021-2026)

Table 36. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value Forecast by Type (2021-2026) (US$ Million)

Table 37. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value Share Forecast by Type (2021-2026)

Table 38. Global Diagnostic Radiopharmaceuticals & Contrast Media Average Selling Price (ASP) Forecast by Type (2021-2026) (US$/Unit)

Table 39. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Application (2015-2020) (K Units)

Table 40. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Share by Application (2015-2020)

Table 41. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Application (2021-2026) (K Units)

Table 42. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Share by Application (2021-2026)

Table 43. Global Diagnostic Radiopharmaceuticals & Contrast Media Production by Regions (2015-2020)

Table 44. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Market Share by Region (2015-2020)

Table 45. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value by Regions (2015-2020) (Million USD)

Table 46. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value Market Share by Regions (2015-2020)

Table 47. Key Diagnostic Radiopharmaceuticals & Contrast Media Players in North America

Table 48. North America Diagnostic Radiopharmaceuticals & Contrast Media Import & Export (2015-2020) (K Units)

Table 49. Key Diagnostic Radiopharmaceuticals & Contrast Media Players in Europe

Table 50. Europe Diagnostic Radiopharmaceuticals & Contrast Media Import & Export (2015-2020) (K Units)

Table 51. Key Diagnostic Radiopharmaceuticals & Contrast Media Players in China

Table 52. China Diagnostic Radiopharmaceuticals & Contrast Media Import & Export (2015-2020) (K Units)

Table 53. Key Diagnostic Radiopharmaceuticals & Contrast Media Players in Japan

Table 54. Japan Diagnostic Radiopharmaceuticals & Contrast Media Import & Export (2015-2020) (K Units)

Table 55. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Regions (2015-2020) (K Units)

Table 56. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Market Share by Regions (2015-2020)

Table 57. The Top Diagnostic Radiopharmaceuticals & Contrast Media Consumers (regions/countries) and Share of Total Diagnostic Radiopharmaceuticals & Contrast Media Consumption (K Units) in 2015 VS 2019

Table 58. North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Type (2015-2020) (K Units)

Table 59. North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Application (2015-2020) (K Units)

Table 60. North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Countries (2015-2020) (K Units)

Table 61. Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Type (2015-2020) (K Units)

Table 62. Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Application (2015-2020) (K Units)

Table 63. Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Countries (2015-2020) (K Units)

Table 64. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Type (2015-2020) (K Units)

Table 65. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Application (2015-2020) (K Units)

Table 66. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Regions (2015-2020) (K Units)

Table 67. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Consumption Market Share by Countries (2015-2020)

Table 68. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Type (2015-2020) (K Units)

Table 69. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Application (2015-2020) (K Units)

Table 70. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Countries (2015-2020) (K Units)

Table 71. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Type (2015-2020) (K Units)

Table 72. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Application (2015-2020) (K Units)

Table 73. Amag Pharmaceuticals Corporation Information

Table 74. Amag Pharmaceuticals Description and Business Overview

Table 75. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 76. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Products and Services

Table 77. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media SWOT Analysis

Table 78. Amag Pharmaceuticals Recent Development

Table 79. Bayer Healthcare Corporation Information

Table 80. Bayer Healthcare Description and Business Overview

Table 81. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 82. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Products and Services

Table 83. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media SWOT Analysis

Table 84. Bayer Healthcare Recent Development

Table 85. Bracco Imaging Corporation Information

Table 86. Bracco Imaging Description and Business Overview

Table 87. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 88. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Products and Services

Table 89. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media SWOT Analysis

Table 90. Bracco Imaging Recent Development

Table 91. Daiichi Sankyo Corporation Information

Table 92. Daiichi Sankyo Description and Business Overview

Table 93. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 94. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Products and Services

Table 95. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media SWOT Analysis

Table 96. Daiichi Sankyo Recent Development

Table 97. GE Healthcare Corporation Information

Table 98. GE Healthcare Description and Business Overview

Table 99. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 100. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Products and Services

Table 101. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media SWOT Analysis

Table 102. GE Healthcare Recent Development

Table 103. Guerbet Corporation Information

Table 104. Guerbet Description and Business Overview

Table 105. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 106. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Products and Services

Table 107. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media SWOT Analysis

Table 108. Guerbet Recent Development

Table 109. Lantheus Corporation Information

Table 110. Lantheus Description and Business Overview

Table 111. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 112. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Products and Services

Table 113. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media SWOT Analysis

Table 114. Lantheus Recent Development

Table 115. Mallinckrodt Corporation Information

Table 116. Mallinckrodt Description and Business Overview

Table 117. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 118. Mallinckrodt Recent Development

Table 119. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Products and Services

Table 120. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media SWOT Analysis

Table 121. Medtronic Corporation Information

Table 122. Medtronic Description and Business Overview

Table 123. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 124. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Products and Services

Table 125. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media SWOT Analysis

Table 126. Medtronic Recent Development

Table 127. Nordion Corporation Information

Table 128. Nordion Description and Business Overview

Table 129. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 130. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Products and Services

Table 131. Nordion Diagnostic Radiopharmaceuticals & Contrast Media SWOT Analysis

Table 132. Nordion Recent Development

Table 133. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value Forecast by Region (2021-2026) (US$ Million)

Table 134. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value Forecast by Region (2021-2026) (US$ Million))

Table 135. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Forecast by Region (2021-2026) (K Units)

Table 136. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Forecast by Region (2021-2026) (K Units)

Table 137. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Region (2021-2026) (K Units)

Table 138. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Region (2021-2026) (K Units)

Table 139. North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Country (2021-2026) (K Units)

Table 140. Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Country 2021-2026 (K Units)

Table 141. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Region (2021-2026) (K Units)

Table 142. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Country 2021-2026 (K Units)

Table 143. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Country 2021-2026 (K Units)

Table 144. Diagnostic Radiopharmaceuticals & Contrast Media Distributors List

Table 145. Diagnostic Radiopharmaceuticals & Contrast Media Customers List

Table 146. Key Opportunities

Table 147. Key Challenges

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Diagnostic Radiopharmaceuticals & Contrast Media Product Picture

Figure 2. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Shar by Type 2015-2026

Figure 3. Radiopharmaceuticals Pictures

Figure 4. Contrast Media Pictures

Figure 5. Hospital Use Case

Figure 6. Clinic Use Case

Figure 7. Other Use Case

Figure 8. Diagnostic Radiopharmaceuticals & Contrast Media Report Years Considered

Figure 9. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value Growth Rate 2015-2026 (US$ Million)

Figure 10. Global Diagnostic Radiopharmaceuticals & Contrast Media Production 2015-2026 (K Units)

Figure 11. Global Diagnostic Radiopharmaceuticals & Contrast Media Capacity 2015-2026 (K Units)

Figure 12. Global Diagnostic Radiopharmaceuticals & Contrast Media Price 2015-2026 (US$/Unit)

Figure 13. Global Diagnostic Radiopharmaceuticals & Contrast Media Growth Rate of Key Region: 2015 VS 2021 VS 2026 (US$ Million)

Figure 14. Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Region: 2020 VS 2026

Figure 15. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Share by Manufacturers in 2019

Figure 16. The 5 and 10 Largest Manufacturers in the World: Market Share by Diagnostic Radiopharmaceuticals & Contrast Media Production in 2019

Figure 17. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Manufacturers in 2019

Figure 18. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 19. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Market Share by Type (2015-2020)

Figure 20. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Market Share by Type in 2015 & 2020

Figure 21. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value Market Share by Type (2015-2020)

Figure 22. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value Market Share by Type in 2019

Figure 23. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Market Share Forecast by Type (2021-2026)

Figure 24. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value Market Share Forecast by Type in 2019

Figure 25. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Price Range (2015-2020)

Figure 26. Global Consumption Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application in 2015 & 2020

Figure 27. Global Consumption Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application in 2021 & 2026

Figure 28. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Market Share by Regions (2015-2020)

Figure 29. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value Market Share by Regions (2015-2020)

Figure 30. North America Diagnostic Radiopharmaceuticals & Contrast Media Production Growth Rate 2015-2020 (K Units)

Figure 31. North America Diagnostic Radiopharmaceuticals & Contrast Media Production Value Growth Rate 2015-2020 (US$ Million)

Figure 32. Key Diagnostic Radiopharmaceuticals & Contrast Media Players Market Share in North America in 2019

Figure 33. Europe Diagnostic Radiopharmaceuticals & Contrast Media Production Growth Rate 2015-2020 (K Units)

Figure 34. Europe Diagnostic Radiopharmaceuticals & Contrast Media Production Value Growth Rate 2015-2020 (US$ Million)

Figure 35. Key Diagnostic Radiopharmaceuticals & Contrast Media Players Market Share in Europe in 2019

Figure 36. China Diagnostic Radiopharmaceuticals & Contrast Media Production Growth Rate 2015-2020 (K Units)

Figure 37. China Diagnostic Radiopharmaceuticals & Contrast Media Production Value Growth Rate 2015-2020 (US$ Million)

Figure 38. Key Diagnostic Radiopharmaceuticals & Contrast Media Players Market Share in China in 2019

Figure 39. Japan Diagnostic Radiopharmaceuticals & Contrast Media Production Growth Rate 2015-2020 (K Units)

Figure 40. Japan Diagnostic Radiopharmaceuticals & Contrast Media Production Value Growth Rate 2015-2020 (US$ Million)

Figure 41. Key Diagnostic Radiopharmaceuticals & Contrast Media Players Market Share in Japan in 2019

Figure 42. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Market Share by Region (2015-2020)

Figure 43. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Market Share by Region in 2015 VS 2019

Figure 44. North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 45. North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Market Share by Type in 2019

Figure 46. North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Market Share by Application in 2019

Figure 47. North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Market Share by Countries in 2019

Figure 48. U.S. Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 49. Canada Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 50. Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 51. Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption Market Share by Type in 2019

Figure 52. Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption Market Share by Application in 2019

Figure 53. Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption Market Share by Countries in 2019

Figure 54. Germany Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 55. France Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 56. U.K. Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 57. Italy Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 58. Russia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 59. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 60. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Consumption Market Share by Type in 2019

Figure 61. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Consumption Market Share by Application in 2019

Figure 62. China Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 63. Japan Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 64. South Korea Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 65. India Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 66. Australia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 67. Taiwan Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 68. Indonesia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 69. Thailand Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 70. Malaysia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 71. Philippines Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 72. Vietnam Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 73. Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 74. Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Market Share by Type in 2019

Figure 75. Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Market Share by Application in 2019

Figure 76. Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Market Share by Countries

Figure 77. Mexico Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 78. Brazil Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 79. Argentina Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 80. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 81. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption Market Share by Type in 2019

Figure 82. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption Market Share by Application in 2019

Figure 83. Turkey Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 84. Saudi Arabia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 85. UAE Diagnostic Radiopharmaceuticals & Contrast Media Consumption Growth Rate (2015-2020) (K Units)

Figure 86. Global Diagnostic Radiopharmaceuticals & Contrast Media Capacity Forecast 2021-2026 (K Units)

Figure 87. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Forecast 2021-2026 (K Units)

Figure 88. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value Forecast 2021-2026 (US$ Million)

Figure 89. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value Forecast by Regions 2021-2026 (US$ Million)

Figure 90. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value Market Share Forecast by Regions 2021-2026

Figure 91. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Forecast by Regions 2021-2026 (K Units)

Figure 92. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Market Share Forecast by Regions 2021-2026

Figure 93. North America Diagnostic Radiopharmaceuticals & Contrast Media Production Forecast 2021-2026 (K Units)

Figure 94. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast 2021-2026 (US$ Million)

Figure 95. Europe Diagnostic Radiopharmaceuticals & Contrast Media Production Forecast 2021-2026 (K Units)

Figure 96. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast 2021-2026 (US$ Million)

Figure 97. China Diagnostic Radiopharmaceuticals & Contrast Media Production Forecast 2021-2026 (K Units)

Figure 98. China Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast 2021-2026 (US$ Million)

Figure 99. Japan Diagnostic Radiopharmaceuticals & Contrast Media Production Forecast 2021-2026 (K Units)

Figure 100. Japan Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast 2021-2026 (US$ Million)

Figure 101. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Forecast by Type 2021-2026 (K Units)

Figure 102. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Market Share Forecast by Type 2021-2026

Figure 103. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value Forecast by Type 2021-2026 (US$ Million)

Figure 104. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value Market Share Forecast by Type 2021-2026

Figure 105. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Application 2021-2026 (K Units)

Figure 106. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Market Share Forecast by Application 2021-2026

Figure 107. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Regions 2021-2026 (K Units)

Figure 108. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Market Share Forecast by Regions 2021-2026

Figure 109. U.S. Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 110. Canada Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 111. Germany Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 112. France Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 113. U.K. Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 114. Italy Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 115. Russia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 116. China Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 117. Japan Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 118. South Korea Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 119. India Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 120. Australia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 121. Taiwan Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 122. Indonesia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 123. Thailand Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 124. Malaysia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 125. Philippines Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 126. Vietnam Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 127. Mexico Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 128. Brazil Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 129. Argentina Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 130. Turkey Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 131. Saudi Arabia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 132. UAE Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 133. Diagnostic Radiopharmaceuticals & Contrast Media Value Chain

Figure 134. Bottom-up and Top-down Approaches for This Report

Figure 135. Data Triangulation

Figure 136. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Forecast by Type 2021-2026 (K Units)

Figure 137. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Market Share Forecast by Type 2021-2026

Figure 138. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value Forecast by Type 2021-2026 (US$ Million)

Figure 139. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Value Market Share Forecast by Type 2021-2026

Figure 140. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Application 2021-2026 (K Units)

Figure 141. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Market Share Forecast by Application 2021-2026

Figure 142. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Regions 2021-2026 (K Units)

Figure 143. Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Market Share Forecast by Regions 2021-2026

Figure 144. U.S. Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 145. Canada Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 146. Germany Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 147. France Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 148. U.K. Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 149. Italy Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 150. Russia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast 2021-2026 (K Units)

Figure 151. China Diagnostic Radiopharmaceuticals & Contrast Media Consumption